Stocks & Investing
Stocks and Investing
Stocks and Investing
Thu, May 4, 2023
[ Thu, May 04th 2023
] - WOPRAI
[ Thu, May 04th 2023
] - WOPRAI
[ Thu, May 04th 2023
] - WOPRAI
[ Thu, May 04th 2023
] - WOPRAI
[ Thu, May 04th 2023
] - WOPRAI
[ Thu, May 04th 2023
] - WOPRAI
[ Thu, May 04th 2023
] - WOPRAI
[ Thu, May 04th 2023
] - WOPRAI
[ Thu, May 04th 2023
] - WOPRAI
[ Thu, May 04th 2023
] - WOPRAI
[ Thu, May 04th 2023
] - WOPRAI
[ Thu, May 04th 2023
] - WOPRAI
[ Thu, May 04th 2023
] - WOPRAI
[ Thu, May 04th 2023
] - WOPRAI
[ Thu, May 04th 2023
] - WOPRAI
[ Thu, May 04th 2023
] - WOPRAI
[ Thu, May 04th 2023
] - WOPRAI
[ Thu, May 04th 2023
] - WOPRAI
[ Thu, May 04th 2023
] - WOPRAI
[ Thu, May 04th 2023
] - WOPRAI
[ Thu, May 04th 2023
] - WOPRAI
[ Thu, May 04th 2023
] - WOPRAI
[ Thu, May 04th 2023
] - WOPRAI
[ Thu, May 04th 2023
] - WOPRAI
[ Thu, May 04th 2023
] - WOPRAI
[ Thu, May 04th 2023
] - WOPRAI
[ Thu, May 04th 2023
] - WOPRAI
[ Thu, May 04th 2023
] - WOPRAI
[ Thu, May 04th 2023
] - WOPRAI
[ Thu, May 04th 2023
] - WOPRAI
Mason Carrico Reiterated (TXG) at Buy and Held Target at $65 on, May 4th, 2023
Mason Carrico of Stephens & Co., Reiterated "10x Genomics, Inc." (TXG) at Buy and Held Target at $65 on, May 4th, 2023.
Mason has made no other calls on TXG in the last 4 months.
There are 2 other peers that have a rating on TXG. Out of the 2 peers that are also analyzing TXG, 1 agrees with Mason's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- John Sourbeer of "UBS" Initiated at Hold and Held Target at $50 on, Thursday, February 2nd, 2023
This is the rating of the analyst that currently disagrees with Mason
- Tejas Savant of "Morgan Stanley" Maintained at Buy with Increased Target to $65 on, Thursday, February 16th, 2023
